Development of DNA Bio-chip for Detection of Mutations of rpoB, embB and inhA Genes in Drug-Resistant Mycobacterium Tuberculosis
Authors:
- 2 May 2022
- journal article
- research article
- Published by Springer Nature in Indian Journal of Clinical Biochemistry
- Vol. 38 (2) , 242-250
Abstract
Drug-resistant (DR) tuberculosis (TB) is a global threat to health security and TB control programs. Since conventional drug susceptibility testing (DST) takes several weeks, we have developed a molecular method for the rapid identification of DR strains of Mycobacterium Tuberculosis (M.tb) utilizing DNA bio-chips. DNA bio-chips were prepared by immobilizing oligonucleotides (probes) on highly microporous polycarbonate track-etched membranes (PC-TEM) as novel support. Bio-chip was designed to contain 15 specific probes to detect mutations in three genes (rpoB, embB, and inhA). A sensitive and specific chemiluminescence based bio-chip assay was developed based on multiplex PCR followed by hybridization on bio-chip. Fifty culture isolates were used to evaluate the ability of in-house developed bio-chip to detect the mutations. Bio-chip analysis shows that 37.7% of samples show wild type sequences, 53.3% of samples were monoresistance showing resistance to either rifampicin (RMP), isoniazid (INH), or ethambutol (EMB). 4.4% of samples were polydrug resistant showing mutations in both the rpoB gene and embB gene while 4.4% of samples were multidrug-resistant (MDR), harboring mutations in the rpoB and inhA genes. The results were compared with DST and sequencing. Compared to sequencing, bio-chip assay shows a sensitivity of 96.5% and specificity of 100% for RMP resistance. For EMB and INH, the results were in complete agreement with sequencing. This study demonstrates the first-time use of PC-TEMs for developing DNA bio-chip for the detection of mutations associated with drug resistance in M.tb. Developed DNA bio-chip accurately detected different mutations present in culture isolates and thus provides detailed and reliable data for clinical diagnosis.Keywords
This publication has 36 references indexed in Scilit:
- Detection of second-line drug resistance in Mycobacterium tuberculosis using oligonucleotide microarraysBMC Infectious Diseases, 2013
- Multidrug-Resistant Tuberculosis Drug Susceptibility and Molecular Diagnostic TestingThe American Journal of the Medical Sciences, 2013
- Rapid Detection of Multidrug-Resistant Mycobacterium tube rculosis by Use of Real-Time PCR and High-Resolution Melt AnalysisJournal of Clinical Microbiology, 2010
- New diagnostics for tuberculosis: fulfilling patient needs firstJournal of the International AIDS Society, 2010
- Five-antituberculosis Drug-resistance Genes Detection Using Array SystemJournal of Clinical Biochemistry and Nutrition, 2008
- rpoB gene sequencing and spoligotyping of multidrug-resistant Mycobacterium tuberculosis isolates from IndiaInfection, Genetics and Evolution, 2006
- Evaluation of the TB-Biochip Oligonucleotide Microarray System for Rapid Detection of Rifampin Resistance in Mycobacterium tuberculosisJournal of Clinical Microbiology, 2006
- Multiplex Detection of Mutations in Clinical Isolates of Rifampin-Resistant Mycobacterium tuberculosis by Short Oligonucleotide Ligation Assay on DNA ChipsJournal of Clinical Microbiology, 2004
- Multicenter evaluation of reverse line blot assay for detection of drug resistance in Mycobacterium tuberculosis clinical isolatesJournal of Microbiological Methods, 2004
- Species level identification of non-tuberculous mycobacteria from South Indian BCG trial area during 1981Tubercle, 1985